2019创伤性休克急救复苏创新技术临床应用中国专家共识  

Chinese expert consensus on the clinical application of innovative first-aid resuscitation technology for traumatic shock in 2019

作　　者：中国研究型医院学会卫生应急学专业委员会、心肺复苏学专业委员会 河南省医院协会心肺复苏专业委员会 张思森 岳茂兴[3] 王立祥[4] Health Emergency Committee of Chinese Research Hospital Association;Cardiopulmonary Resuscitation Specialized Committee of Chinese Research Hospital Association;Zhang Sisen;Yue Maoxing;Wang Lixiang

机构地区：[1]不详 [2]河南中医药大学人民医院/南方医科大学第二临床医学院 [3]战略支援部队特色医学中心/江苏大学附属武进医院急诊医学科 [4]解放军总医院第二医学中心

出　　处：《中华危重病急救医学》2019年第3期257-263,共7页Chinese Critical Care Medicine

基　　金：国家重点基础研究发展计划(973计划)项目(2005CB522602);国家科技支撑计划项目(2014BAL05B06);国家重点实验室开放基金项目(SKLKF201312);河南省科技惠民计划项目(152207310007);河南省医学科技攻关计划项目(201303221,2018010045,2018020828);江苏省卫生厅重大项目(Z201013);河南省郑州市科技计划项目(131PLJRC682);河南省郑州市科技发展计划项目(20130595,20140452,20150060);江苏省常州市科技计划项目(CJ20140001).

摘　　要：为了提高中国创伤性休克及心搏骤停的临床救治技术培训与普及,中国研究型医院学会卫生应急学专业委员会、中国研究型医院学会心肺复苏学专业委员会、河南省医院协会心肺复苏专业委员会共同制定了《2019创伤性休克急救复苏创新技术临床应用中国专家共识》。本共识针对创伤性休克院前无法输血及血制品的紧急情况,解决了容量复苏晶胶液搭配与配比的问题。高渗晶胶复合液救治创伤性休克,用量小、稳定血压效果好,可替代血及血制品,提高了创伤性休克患者转运至医院的安全性,为抢救生命提供了机会。同时,腹部提压心肺复苏(CPR)解决了创伤后心搏骤停患者不能实施传统胸外按压CPR的救治难题,大大提高了院前创伤性休克患者的救治成功率。鉴于我国急救医疗的实际需求和胸部创伤不能进行胸部CPR的特点,采取"政、产、学、研、用"相结合,腹部提压CPR研制成功并推广应用。本专家共识总结了迄今为止国内外已发表的关于创伤性休克与创伤性心搏骤停的科学证据,并基于中国的国情提出了创伤性休克急救复苏创新技术临床应用专家共识。本共识融入了中外创伤性休克及CPR培训的学者智慧与理念,必将使中国创伤性休克与创伤性心搏骤停培训进入一个针对性强、起效快、副作用少、救治率高的新阶段。To promote the clinical treatment technical training and popularization of traumatic shock and cardiac arrest, Health Emergency Committee of Chinese Research Hospital Association, Cardiopulmonary Resuscitation Specialized Committee of Chinese Research Hospital Association, Cardiopulmonary Resuscitation Specialized Committee of Henan Hospital Association jointly established "Chinese expert consensus on the clinical application of innovative first-aid resuscitation technology for traumatic shock in 2019". This consensus has solved the problem of volume resuscitated gel mix and ratio in the emergency situation of pre-hospital transfusion and blood products unable to be used in traumatic shock. Hypertonic gel compound liquid can treat traumatic shock with small dosage and good effect of stabilizing blood pressure, which can replace whole blood and other blood products, improve the safety of transport to hospital, and provide an opportunity for life-saving surgery. At the same time, abdominal lifting and compression cardiopulmonary resuscitation (CPR) has solved the difficulty of treating patients with post-traumatic cardiac arrest who cannot perform traditional chest compressive CPR, and greatly improved the success rate of pre-hospital treatment for patients with traumatic shock. In view of the actual demand of emergency medical treatment in China and the contraband of chest CPR for chest trauma, the combination of "administration, production, study, research and application" was adopted, and the abdominal lifting and compression CPR was successfully developed and popularized. This expert consensus summarized the scientific evidence on traumatic shock and traumatic cardiac arrest published at home and abroad so far, and put forward the expert consensus on the clinical application of innovative first-aid resuscitation technology for traumatic shock based on Chinese national conditions. This consensus incorporated the wisdom and philosophy of Chinese and foreign scholars in the training of traumatic shock and CPR, and

关 键 词：休克 创伤性 心搏骤停 复苏 专家共识 

分 类 号：R605.971[医药卫生—急诊医学]